AN2 Therapeutics, Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
12 sales (4 not pre-planned) · 1 purchase
- Eizen Joshua MSee Remarks · Nov 5, 2026Sold 2,826 sharesabout $12 thousand · not pre-planned
- Readnour Robin ShaneBoard member · Sep 9, 2026Sold 523 sharesabout $3 thousand · pre-planned
- Readnour Robin ShaneBoard member · Sep 9, 2026Sold 585 sharesabout $4 thousand · pre-planned
- Readnour Robin ShaneBoard member · Sep 8, 2026Sold 4,725 sharesabout $28 thousand · pre-planned
- Readnour Robin ShaneBoard member · Sep 8, 2026Sold 5,294 sharesabout $32 thousand · pre-planned
- Readnour Robin ShaneBoard member · Sep 3, 2026Sold 2,877 sharesabout $17 thousand · pre-planned
- Readnour Robin ShaneBoard member · Sep 3, 2026Sold 3,223 sharesabout $20 thousand · pre-planned
- Williams Sarah JoannePrincipal Accounting Officer · Sep 1, 2026Sold 272 sharesabout $2 thousand · not pre-planned
- FitzPatrick Margaret MBoard member · Sep 1, 2026Bought 2,098 sharesabout $12 thousand ·
- Readnour Robin ShaneBoard member · Aug 17, 2026Sold 16,696 sharesabout $100 thousand · pre-planned
- Readnour Robin ShaneBoard member · Aug 17, 2026Sold 18,706 sharesabout $112 thousand · pre-planned
- Eizen Joshua MSee Remarks · Jul 8, 2026Sold 5,945 sharesabout $25 thousand · not pre-planned
- Williams Sarah JoannePrincipal Accounting Officer · May 29, 2026Sold 265 sharesabout $1 thousand · not pre-planned
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.